Peng Song

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Topics

Ejection Fraction

Immune Response

Contrast Enhanced

Small Cell Lung Cancer

Top Venues

Thoracic cancer

Infection and drug resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Peng Song, Huaichen Li, Tingting Liu, Yao Liu, Xiaobin Ma, Lili Su
Disseminated Strongyloidiasis Misdiagnosed as Guillain-Barré Syndrome: The Value of High-Throughput Genetic Sequencing of Pathogenic Microorganisms in Parasitic Infections. Infection and drug resistance 15 (2022)
Peng Song, Dongliang Yang, Hanping Wang, Xiaoxia Cui, Xiao-Yan Si, Xiao-Tong Zhang, Li Zhang
Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patients. Thoracic cancer 11 (6) (2020)
Peng Song, Xiao-Tong Zhang, Xiaoxia Cui, Li Zhang
Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients. Thoracic cancer 11 (9) (2020)
Peng Song, Xiaotong Zhang, Dongliang Yang, Hanping Wang, Xiao-Yan Si, Li Zhang
Single-center study to determine the safety and efficacy of CT-707 in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small-cell lung cancer. Thoracic cancer 11 (5) (2020)
Xiao-Yan Si, Peng Song, Jun Ni, Mingyi Di, Chunxia He, Li Zhang, Xiaowei Liu, Yue Li, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Xu Yang, Mengzhao Wang, Li Zhang
Management of immune checkpoint inhibitor-related adverse events: A review of case reports. Thoracic cancer 11 (3) (2020)
Peng Song, Dongliang Yang, Hanping Wang, Xiaoxia Cui, Xiao-Yan Si, Xiao-Tong Zhang, Li Zhang
Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients. Thoracic cancer 11 (6) (2020)
Peng Song, Jingcheng Zhang, Congcong Shang, Li Zhang
Curative effect assessment of immunotherapy for non-small cell lung cancer: The "blind area" of Immune Response Evaluation Criteria in Solid Tumors (iRECIST). Thoracic cancer 10 (4) (2019)
Peng Song, Xiaoxia Cui, Li Bai, Xiangdong Zhou, Xiaoli Zhu, Jian Zhang, Faguang Jin, Jianping Zhao, Chengzhi Zhou, Yanbin Zhou, Xiaoju Zhang, Kai Wang, Qi Wang, Yao Yu, Xiaoyu Zhang, Chunxue Bai, Li Zhang
Molecular characterization of clinical responses to PD-1/PD-L1 inhibitors in non-small cell lung cancer: Predictive value of multidimensional immunomarker detection for the efficacy of PD-1 inhibitors in Chinese patients. Thoracic cancer 10 (5) (2019)
Peng Song, Jingcheng Zhang, Congcong Shang, Li Zhang
Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant. Thoracic cancer 9 (10) (2018)